Tai Tsun Wu

Tai Tsun Wu is a distinguished physicist affiliated with Harvard University, where he conducts both theoretical and experimental research in high-energy particle physics. He earned his academic credentials prior to establishing a prolific career marked by significant contributions to the field. Wu’s research primarily focuses on the foundations of the Standard Model, quantum chromodynamics (QCD), and particle interactions, with particular emphasis on scattering amplitudes, gauge coupling constants, and the dynamics of high-energy collisions. His work bridges theoretical frameworks and experimental validation, as evidenced by his involvement in crystal structure determinations and analyses of particle behavior. Among his notable contributions is the exploration of relationships between gauge coupling constants, advancing the conceptual understanding of fundamental forces. With an h-index of 65 and over 490 publications, his sustained scholarly output underscores his impact on particle physics. Wu’s recent publications, including studies on the Standard Model and scattering amplitudes, reflect his ongoing engagement with core questions in theoretical and experimental physics, maintaining an active research profile through 2023. Their recent contributions to the field are exemplified by influential works such as "Approach to headache disorders and the management of migraine: consensus guidelines from the Headache Society of Singapore, first edition (2023)", and "Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial".